Higher Dosing 'Difficult to Straddle'

August 1, 2003

Andrew Bowser is a medical writer based in Brooklyn, New York.

Chicago - Escalating doses of an antibody to CTLA-4 in conjunction with a peptide vaccine showed the induction of antigen-specific immune responses and potential evidence of autoimmunity in patients with stage III/IV resected melanoma, according to Jeffrey M. Weber, M.D., Ph.D.

Related Content: